Session date: 
Friday, June 8, 2018 - 12:00pm to 1:00pm
Medical College of Wisconsin
8701 W. Watertown Plank Road
Alumni Center (MEB-M1060)
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

In November 2000, Amendment 20 was passed in Colorado which legalized limited amounts of medical marijuana for patients and their primary caregivers.  In November 2012, Amendment 64 was passed in Colorado which legalized recreational marijuana by decriminalizing the possession of marijuana and regulating the sale of marijuana. On January 1, 2014 recreational marijuana stores opened to the public.  As of April 2018, twenty-nine (29) states (includes the District of Columbia) have legalized marijuana for medical use. Included in these twenty-nine states are nine states (includes the District of Columbia) which have legalized marijuana for recreational use. As states around the country begin to legalize medical and recreational marijuana, it is important to understand the possible effects of legalization on Toxicological analysis and testimony.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 


Physicians Assistants

Allied Health Professionals

Learning objectives: 

At the conclusion of this activity, learners will be able to:

  1. Provide an overview of relevant laws in Colorado and other states with legalized medicinal and/or recreational marijuana.
  2. Discuss analytical challenges regarding the analysis of marijuana in driving under the influence of drugs (DUID) specimens.
  3. Describe how to interpret driving under the influence of marijuana blood results and potential challenges in courtroom testimony.
Faculty & credentials: 
Planning Committee:
David Gummin, MD
Jessica Colon-Franco, PhD, DABCC
Pratistha Ranjitkar, PhD, DABCC
Sara Schreiber, MS, D-ABFT
Greg Wallace


Dan Anderson, M.S., D-ABFT-FT, D-ABC
Laboratory Manager
Toxicology & Drug Chemistry 
Colorado Bureau of Investigation Forensic Services
All persons in control of content have NO relevant financial relationships to disclosure except:


In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

CME Coordinator Contact Information

Shannon Majewski
Phone number: 
+1 (414) 805-6976